Gabrail Cancer Center
Oncology
Dr. Nashat Y. Gabrail, MD
|
|
Give Review
Nashat Gabrail is an expert in the field of Oncology. He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Nashat Gabrail is a published physician as well. He has 22 publications published. The latest was: Szary syndrome associated with phenytoin therapy. He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Community-Based Phase IIIB Trial of Three UPFRONT Bortezomib-Based Myeloma Regimens.
- Letter to the editor: pharmacokinetics of non-intravenous formulations of fentanyl.
- Relationship among circulating tumor cells, CEA and overall survival in patients with metastatic colorectal Cancer.
- Acute leukemia after adjuvant chemotherapy for breast cancer.
- Pulmonary hamartoma Syndrome.
- Sézary Syndrome associated with phenytoin therapy.
- Safety, Pharmacokinetics, and Activity of GRN1005, a Novel Conjugate of Angiopep-2, a Peptide Facilitating Brain Penetration, and Paclitaxel, in Patients with Advanced...
- Fentanyl pectin nasal spray for breakthrough Cancer pain.
- Prognostic significance of circulating tumor cells in patients with metastatic colorectal Cancer.
- Treatment of chemotherapy-induced anemia in breast Cancer: results of a randomized controlled trial of darbepoetin alfa 200 microg every 2 weeks versus epoetin alfa 40...
- Clinical implications of chemotherapy-induced diarrhea in patients with Cancer.
- A phase 2 clinical trial of deforolimus (AP23573, MK-8669), a novel mammalian target of rapamycin inhibitor, in patients with relapsed or refractory hematologic malign...
- TROPICS 1: a phase III, randomized, double-blind, placebo-controlled study of tenecteplase for restoration of function in dysfunctional central venous catheters.
- A multicenter, placebo-controlled, double-blind, multiple-crossover study of Fentanyl Pectin Nasal Spray (FPNS) in the treatment of breakthrough Cancer pain.
- A multicenter, phase 2 study of vascular endothelial growth factor trap (Aflibercept) in platinum- and erlotinib-resistant adenoCarcinoma of the lung.
- Effect of the cytochrome P450 2C19 inhibitor omeprazole on the pharmacokinetics and safety profile of bortezomib in patients with advanced solid tumours, non-Hodgkin''...
- A Phase II Study of Eribulin Mesylate (E7389) in Patients With Advanced, Previously Treated Non-Small-Cell Lung Cancer.
- Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal Cancer.
- A multicenter, randomized trial of long-acting octreotide for the optimum prevention of chemotherapy-induced diarrhea: results of the STOP trial.
- Establishing the dosage equivalency of oxymorphone extended release and oxycodone controlled release in patients with Cancer pain: a randomized controlled study.
- APF530 (Granisetron injection extended-release) in a three-drug regimen for delayed CINV in highly emetogenic chemotherapy.
Schools
University of Mosul College of Medicine
Wg Hosp
Hurley Med Ctr
U Mo
United Kingdom
Procedures Preformed
- Biopsy
- Bone Marrow Aspiration
- Cancer Counseling
- Cancer Pain Management
- View All
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Adult Development Disorders
- Anal and Rectal Cancer
- View All
Doctors Specialties
- Hematology
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Hospital
-
Mercy Medical Center
Drug Facts
| NPI NUMBER | 1104854751 | |
| NPPES Provider LastName | GABRAIL | |
| NPPES Provider FirstName | NASHAT | |
| NPPES Provider ZIPCode | 447182566 | |
| NPPES Provider State | OH | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 1689.0 | |
| Distinct Opioid Count | 3.0 | |
| Opioid Claim Count | 124.0 | |
| Percent Opioid Claims | 7.34 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1104854751 |
| Last Name Of The Provider | GABRAIL |
| First Name Of The Provider | NASHAT |
| View All |
Similar Doctors
|
Dr. Ferdinando Cortese, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nagaprasad Nagajothi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard A. Cooper, MD |
|
|
Dr. Raza A. Khan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard L. Morgan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Prabha S. Murthy, MD |
|
|
Dr. Robert W. Kellermeyer, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Kisa E. Weeman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Sunitha Vemulapalli, MB
This Doctor is OpenDoctor Recommended.
|